CA
EXAS

Continuum Advisory’s Exact Sciences EXAS Stock Holding History

Continuum Advisory’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9
Closed -$458 – 1891
2024
Q3 		$458 Hold
9
– – ﹤0.01% 1806
2024
Q2 		$380 Sell
9
-18
-67% -$990 ﹤0.01% 1635
2024
Q1 		$1.46K Buy
+27
New +$1.71K ﹤0.01% 1385

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Continuum Advisory's EXAS Position: Q4 2024 in Review

Continuum Advisory sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 9 shares — an estimated $458 sold.

Continuum Advisory first reported a position in EXAS in Q1 2024 and held it in 3 quarters. The position peaked at $1.46K in Q1 2024. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Continuum Advisory reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Continuum Advisory sold 9 Exact Sciences shares in Q4 2024, an estimated $458.
  • Continuum Advisory first reported a position in Exact Sciences in Q1 2024 and held it in 3 quarters.
  • Continuum Advisory's Exact Sciences position peaked at $1.46K in Q1 2024.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Continuum Advisory's 13F filing for Q4 2024, filed 18 Feb 2025.